A Case of Hepatitis B Reactivation with Acute Flare Three Months After Tenofovir Prophylaxis Withdrawal in a Allogenic Hematopoietic Stem Cell Transplantation Patient
Journal Title: Viral Hepatitis Journal - Year 2018, Vol 24, Issue 2
Abstract
Hepatitis B virus (HBV) infection is a major health problem worldwide. HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and, prophylactic antiviral treatment is suggested to prevent this phenomenon. However, the duration of antiviral treatment in HSCT patients is not fully defined and the time of immune recovery is considered the best parameter for a drug to be safely interrupted. We aimed to present a case of hepatitis B reactivation after cessation of one-year prophylactic tenofovir treatment in a anti-hepatitis B core immunoglobulin G-positive patient who received allogenic HSCT treatment for chronic lymphocytic leukemia.
Authors and Affiliations
Bilal TOKA, Ahmet Tarık EMİNLER, Ferhat Gürkan ASLAN, Aydın Şeref KÖKSAL, Mustafa ALTINDİŞ
Keywords
Related Articles
- EP ID EP382509
- DOI 10.4274/vhd.2018.0001
- Views 63
- Downloads 0
A Rare Side Effect of Entecavir: Hepatomegaly and Steatosis
Hepatomegaly and steatosis are rare but potentially fatal side-effects of nucleoside analogues. Here, we present the case of development of hepatomegaly and steatosis in a 53-year-old male who had been treated with entec...
Human Pegivirus (GB Virus Type C) and Its Relationship with HIV
Editorial
Saddening Truth of Hepatitis D Infection
.
Acute Viral Hepatitis B with a Severe Clinical Course in Pregnancy: A Case Report
The most common cause of non-pregnancy-specific acute hepatitis during pregnancy is hepatitis B. The clinical course of viral hepatitis B in pregnancy is similar to that in non-pregnant women, and about 1% of patients ma...
In the Light of European Association for the Study of the Liver 2017: Terminology and Approach to Hepatitis B Virus Reactivation in Patients at High Risk
.